Learn More
Description
Specifications
Specifications
| Antigen | PD-L1/B7-H1 |
| Applications | Western Blot, Flow Cytometry, ELISA, Immunohistochemistry, Immunocytochemistry, Immunofluorescence, Immunoprecipitation, Immunohistochemistry (Paraffin), Immunohistochemistry (Frozen), KnockDown, In Situ Hybridization (ISH) |
| Classification | Polyclonal |
| Concentration | 1 mg/mL |
| Conjugate | Unconjugated |
| Dilution | Western Blot 1:1000, Flow Cytometry 0.5 μg/mL, ELISA 1:100 - 1:2000, Immunohistochemistry 1:10-1:500, Immunocytochemistry/Immunofluorescence 1-5 μg/mL, Immunoprecipitation, Immunohistochemistry-Paraffin 1:10-1:500, Immunohistochemistry-Frozen, Immunohistochemistry Whole-Mount, Immunofluorescence 20 μg/mL, Knockdown Validated, Dual RNAscope ISH-IHC |
| Formulation | PBS with 0.02% Sodium Azide |
| Gene Accession No. | NP_054862 |
| Gene Alias | Avelumab, B7-H, B7-H1, B7H1PDCD1L1, CD274 antigenMGC142294, CD274 molecule, PDCD1LG1MGC142296, PD-L1, PD-L1B7 homolog 1, PDL1PDCD1 ligand 1, programmed cell death 1 ligand 1, Programmed death ligand 1 |
| Gene Symbols | CD274 |
| Show More |
By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.
